Amoxyclav

# Amoxyclav (Amoxicillin/Clavulanate) ## Overview - **Classification**: Beta-lactam antibiotic (penicillin class) combined with a Beta-lactamase inhibitor. - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis. Clavulanate protects amoxicillin from beta-lactamase degradation, expanding its spectrum. ## Primary Indications 1. **Acute Otitis Media (AOM)** - Particularly for resistant S. pneumoniae or recurrent AOM. 2. **Acute Bacterial Sinusitis** - For resistant strains or treatment failure with amoxicillin alone. 3. **Community-Acquired Pneumonia (CAP)** - When atypical pathogens are not suspected. 4. **Skin and Soft Tissue Infections** - Including animal/human bites, cellulitis. 5. **Urinary Tract Infections (UTI)** - For complicated cases or resistant pathogens. ## Adult Dosing ### Standard Dosing **Acute Bacterial Sinusitis, CAP, Skin/Soft Tissue Infections** - **Dose**: **875 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every **12 hours (BID)** - **Route**: Oral - **Duration**: 7-10 days, depending on infection severity. **Severe/Recurrent Acute Otitis Media, less severe infections** - **Dose**: **500 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every **8 hours (TID)** - **Route**: Oral - **Duration**: 5-10 days. ### Dose Adjustments - **Renal Impairment**: - **CrCl >30 mL/min**: No adjustment needed. - **CrCl 10-30 mL/min**: **500 mg/125 mg** every **12 hours**. - **CrCl <10 mL/min**: **500 mg/125 mg** every **24 hours**. - **Hemodialysis**: **500 mg/125 mg** every **24 hours**, with an additional dose during/after dialysis. - **Hepatic Impairment**: Use with caution. Monitor liver function periodically. - **Elderly Patients**: No specific dose adjustment unless renal impairment is present. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Use with extreme caution. Limited data. - **Frequency**: Typically **30 mg/kg/day** of amoxicillin component divided every **12 hours**. - **Maximum**: Not well established, follow specialist guidance. - **Special Notes**: Consider single agent amoxicillin if appropriate. Monitor for GI upset. ### Infants (1-12 months) - **Dose (Mild/Moderate)**: **25-45 mg/kg/day** (amoxicillin component) divided every **12 hours (BID)**. - **Dose (Severe/AOM)**: **80-90 mg/kg/day** (amoxicillin component) divided every **12 hours (BID)**. - **Maximum**: Do not exceed **125 mg clavulanate** per dose (based on 400mg/57mg per 5mL suspension). ### Children (1-12 years) - **Dose (Mild/Moderate)**: **25-45 mg/kg/day** (amoxicillin component) divided every **12 hours (BID)**. - **Dose (Severe/AOM/Sinusitis)**: **80-90 mg/kg/day** (amoxicillin component) divided every **12 hours (BID)**. - **Maximum**: Do not exceed adult dose (e.g., **875 mg amoxicillin / 125 mg clavulanate** per dose). ### Adolescents (13-18 years) - **Dose**: Generally follow **adult dosing** recommendations. - **Maximum**: **875 mg amoxicillin / 125 mg clavulanate** per dose, twice daily. ## Safety Information ### Contraindications - **Absolute**: History of severe hypersensitivity reaction (e.g., anaphylaxis, SJS) to amoxicillin, clavulanate, or other beta-lactams. - **Absolute**: History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate use. - **Relative**: History of penicillin allergy (non-severe). ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea, Nausea, Vomiting. - **Common (1-10%)**: Rash, Urticaria, Vaginitis, Headache. - **Serious but Rare**: Anaphylaxis, Clostridioides difficile-associated diarrhea (CDAD), Cholestatic jaundice, Hepatitis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN). ### Key Drug Interactions - **Warfarin**: May increase INR. Monitor INR closely, adjust warfarin dose if needed. - **Methotrexate**: May decrease methotrexate clearance, increasing toxicity. Monitor methotrexate levels. - **Allopurinol**: Increased risk of skin rash. Avoid concomitant use if possible. - **Oral Contraceptives**: Theoretical reduction in efficacy, though not clinically proven for most. Counsel patients on backup methods. ## Monitoring & Follow-up - **Before Treatment**: Check for history of allergies to penicillins or cephalosporins. - **During Treatment**: - Monitor for signs of allergic reaction (rash, dyspnea). - Monitor for severe diarrhea (may indicate CDAD). - Monitor LFTs and renal function during prolonged therapy or in patients with pre-existing impairment. - **Clinical Signs**: Worsening symptoms, new fever, jaundice, dark urine, severe abdominal pain. ## Clinical Pearls - 💡 **Take with food**: Administer at the start of a meal to reduce gastrointestinal side effects. - 💡 **Complete the full course**: Emphasize importance of completing the entire prescribed course, even if symptoms improve. - 💡 **Formulation awareness**: Be aware of different amoxicillin to clavulanate ratios (e.g., 4:1, 7:1, 14:1) to avoid clavulanate overdose, especially in pediatrics. - 💡 **Suspension storage**: Reconstituted oral suspension must be refrigerated and discarded after 10 days. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.